Treatment of acute cholecystitis and risk factors for mortality in hemodialysis patients

Basit Öğe Kaydı
dc.contributor.authorS, Fatih
dc.contributor.authorK, Cüneyt
dc.contributor.authorT, Serdar
dc.contributor.authorŞ, Müfit
dc.contributor.authorS, Kutay
dc.contributor.authorU, Mehmet
dc.contributor.authorÇ, Arif Burak
dc.contributor.authorA, Aydın
dc.date.accessioned2022-10-24T11:43:30Z
dc.date.available2022-10-24T11:43:30Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.description.abstractÖz: Introduction: There have been few studies on the treatment of acute cholecystitis (AC) in hemodialysis (HD) patients. The aim of this study was to investigate the risk factors for mortality in HD patients who developed AC, and to compare the results of treatment. Materials and Methods: The records of HD patients who developed AC between 2009 and 2019 were analyzed retrospectively. The diagnosis and severity of AC was made according to Tokyo Guideline (TG) 18. The American Society of Anesthesiologists (ASA) scores were used for surgical risk. The Charlson comorbidity index (CCI) was used for comorbid conditions of patients. Risk factors were investigated for mortality. Medical treatment and cholecystectomy results were compared. Results: Thirty-four patients were included in the study. Mortality occurred in six patients (17.6%). Age ?65 years, an ASA IV score, a CCI ?8, Tokyo Guideline 18 (TG 18) grade III, and blood urea nitrogen ?60 mg/dL were increased those who died (p=0.03, p=0.001, p=0.02, p<0.001, p=0.03; respectively). According to TG 18, there was no difference between the medical treatment and cholecystectomy groups in terms of clinical success, readmission, and mortality rates (p=1.00, p=0.64, p=1.00; respectively). However, length of hospital stay was longer in the cholecystectomy group (p=0.01). Conclusion: Despite the suggestions in the TG 18, medical treatment and in-hospital early cholecystectomy can be performed with similar clinical success, readmission, and mortality rates in HD patients who develop ACen_US
dc.identifier.citationAKTAŞ A, KAYAALP C, ULUŞAHİN M, ÇEKİÇ A, ŞANSAL M, SAĞLAM K, TÜRKYILMAZ S, SÜMER F (2020). Treatment of acute cholecystitis and risk factors for mortality in hemodialysis patients. Laparoscopic Endoscopic Surgical Science, 27(4), 220 - 228. 10.14744/less.2020.59354en_US
dc.identifier.doi10.14744/less.2020.59354en_US
dc.identifier.endpage228en_US
dc.identifier.issn2587-0610
dc.identifier.issue4en_US
dc.identifier.startpage220en_US
dc.identifier.trdizinid486376en_US
dc.identifier.urihttps://doi.org/10.14744/less.2020.59354
dc.identifier.urihttps://hdl.handle.net/11616/85193
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/486376
dc.identifier.volume27en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofLaparoscopic Endoscopic Surgical Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTreatment of acute cholecystitis and risk factors for mortality in hemodialysis patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
202.5 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Doyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu